Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://link.springer.com/article/10.1007/s10787-018-0489-6, but it redirected us to https://link.springer.com/article/10.1007/s10787-018-0489-6. The analysis below is for the second page.

Title[redir]:
Cyclooxygenase and lipoxygenase gene expression in the inflammogenesis of breast cancer | Inflammopharmacology
Description:
We examined the expression of major inflammatory genes, cyclooxygenase-1 and 2 (COX1, COX2) and arachidonate 5-lipoxygenase (ALOX5) in 1090 tumor samples of invasive breast cancer from The Cancer Genome Atlas (TCGA). Mean cyclooxygenase expression (COX1 + COX2) ranked in the upper 99th percentile of all 20,531 genes and surprisingly, the mean expression of COX1 was more than tenfold higher than COX2. Highly significant correlations were observed between COX2 with eight tumor-promoting genes (EGR2, IL6, RGS2, B3GNT5, SGK1, SLC2A3, SFRP1 and ETS2) and between ALOX5 and ten tumor promoter genes (CD33, MYOF1, NLRP1, GAB3, CD4, IFR8, CYTH4, BTK, FGR, CD37). Expression of CYP19A1 (aromatase) was significantly correlated with COX2, but only in tumors positive for ER, PR and HER2. Tumor-promoting genes correlated with the expression of COX1, COX2, and ALOX5 are known to effectively increase mitogenesis, mutagenesis, angiogenesis, cell survival, immunosuppression and metastasis in the pathogenesis of breast cancer.

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Science

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We see no obvious way the site makes money.

Not every website is profit-driven; some are created to spread information or serve as an online presence. Websites can be made for many reasons. This could be one of them. Doi.org has a revenue plan, but it's either invisible or we haven't found it.

Keywords {🔍}

pubmed, cancer, google, scholar, article, cas, breast, central, expression, cox, cyclooxygenase, tumor, cells, res, gene, cell, human, harris, lipoxygenase, inflammation, prostaglandin, genes, metastasis, access, growth, liu, data, receptor, role, biol, factor, zhang, wang, privacy, cookies, content, aromatase, sci, nature, nat, rev, publish, research, search, inflammogenesis, genome, open, signaling, mol, med,

Topics {✒️}

anti-csf-1r antibody reveals c-fms proto-oncogene product month download article/chapter colony-stimulating factor 1 tyrosine kinase signaling epstein–barr virus infection article inflammopharmacology aims lipoxygenase gene expression gene expression patterns ohio state university acyl-coa synthetase 4 rna-seq data tumor-promoting genes correlated cox-2/pge2 upregulation contributes full article pdf related subjects die krankhaften geschwulste privacy choices/manage cookies national cancer institute breast carcinoma cells tumor-promoting genes normalizing egfr expression induces slug expression prostate cancer cells breast tumor microenvironment human breast tumor invasive breast cancer human breast cancer breast cancer subtypes breast cancer malignancy human breast tumours feline sarcoma virus colorectal cancer prevention breast cancer biology 5-lipoxygenase converging functions 11β-prostaglandin f2α european economic area major inflammatory genes upper 99th percentile highly significant correlations effectively increase mitogenesis prognostic immunity markers abou-issa hm glut3 glucose transporters accurate transcript quantification børresen-dale al arachidonic acid metabolism mammary epithelial subpopulations perou cm bioactive metabolite catalyzed

Questions {❓}

  • Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow?
  • Williams CS, DuBois RN (1996) Prostaglandin endoperoxide synthase: why two isoforms?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Cyclooxygenase and lipoxygenase gene expression in the inflammogenesis of breast cancer
         description:We examined the expression of major inflammatory genes, cyclooxygenase-1 and 2 (COX1, COX2) and arachidonate 5-lipoxygenase (ALOX5) in 1090 tumor samples of invasive breast cancer from The Cancer Genome Atlas (TCGA). Mean cyclooxygenase expression (COX1 + COX2) ranked in the upper 99th percentile of all 20,531 genes and surprisingly, the mean expression of COX1 was more than tenfold higher than COX2. Highly significant correlations were observed between COX2 with eight tumor-promoting genes (EGR2, IL6, RGS2, B3GNT5, SGK1, SLC2A3, SFRP1 and ETS2) and between ALOX5 and ten tumor promoter genes (CD33, MYOF1, NLRP1, GAB3, CD4, IFR8, CYTH4, BTK, FGR, CD37). Expression of CYP19A1 (aromatase) was significantly correlated with COX2, but only in tumors positive for ER, PR and HER2. Tumor-promoting genes correlated with the expression of COX1, COX2, and ALOX5 are known to effectively increase mitogenesis, mutagenesis, angiogenesis, cell survival, immunosuppression and metastasis in the pathogenesis of breast cancer.
         datePublished:2018-05-07T00:00:00Z
         dateModified:2018-05-07T00:00:00Z
         pageStart:909
         pageEnd:923
         sameAs:https://doi.org/10.1007/s10787-018-0489-6
         keywords:
            Breast cancer
            Cyclooxygenase
            Lipoxygenase
            RNA sequence data
            Pharmacology/Toxicology
            Immunology
            Rheumatology
            Gastroenterology
            Dermatology
            Allergology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10787-018-0489-6/MediaObjects/10787_2018_489_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10787-018-0489-6/MediaObjects/10787_2018_489_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10787-018-0489-6/MediaObjects/10787_2018_489_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10787-018-0489-6/MediaObjects/10787_2018_489_Fig4_HTML.gif
         isPartOf:
            name:Inflammopharmacology
            issn:
               1568-5608
               0925-4692
            volumeNumber:26
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer International Publishing
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Brian M. Kennedy
               affiliation:
                     name:The Ohio State University
                     address:
                        name:Colleges of Public Health and Medicine, The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Randall E. Harris
               affiliation:
                     name:The Ohio State University
                     address:
                        name:Colleges of Public Health and Medicine, The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Cyclooxygenase and lipoxygenase gene expression in the inflammogenesis of breast cancer
      description:We examined the expression of major inflammatory genes, cyclooxygenase-1 and 2 (COX1, COX2) and arachidonate 5-lipoxygenase (ALOX5) in 1090 tumor samples of invasive breast cancer from The Cancer Genome Atlas (TCGA). Mean cyclooxygenase expression (COX1 + COX2) ranked in the upper 99th percentile of all 20,531 genes and surprisingly, the mean expression of COX1 was more than tenfold higher than COX2. Highly significant correlations were observed between COX2 with eight tumor-promoting genes (EGR2, IL6, RGS2, B3GNT5, SGK1, SLC2A3, SFRP1 and ETS2) and between ALOX5 and ten tumor promoter genes (CD33, MYOF1, NLRP1, GAB3, CD4, IFR8, CYTH4, BTK, FGR, CD37). Expression of CYP19A1 (aromatase) was significantly correlated with COX2, but only in tumors positive for ER, PR and HER2. Tumor-promoting genes correlated with the expression of COX1, COX2, and ALOX5 are known to effectively increase mitogenesis, mutagenesis, angiogenesis, cell survival, immunosuppression and metastasis in the pathogenesis of breast cancer.
      datePublished:2018-05-07T00:00:00Z
      dateModified:2018-05-07T00:00:00Z
      pageStart:909
      pageEnd:923
      sameAs:https://doi.org/10.1007/s10787-018-0489-6
      keywords:
         Breast cancer
         Cyclooxygenase
         Lipoxygenase
         RNA sequence data
         Pharmacology/Toxicology
         Immunology
         Rheumatology
         Gastroenterology
         Dermatology
         Allergology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10787-018-0489-6/MediaObjects/10787_2018_489_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10787-018-0489-6/MediaObjects/10787_2018_489_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10787-018-0489-6/MediaObjects/10787_2018_489_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10787-018-0489-6/MediaObjects/10787_2018_489_Fig4_HTML.gif
      isPartOf:
         name:Inflammopharmacology
         issn:
            1568-5608
            0925-4692
         volumeNumber:26
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer International Publishing
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Brian M. Kennedy
            affiliation:
                  name:The Ohio State University
                  address:
                     name:Colleges of Public Health and Medicine, The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Randall E. Harris
            affiliation:
                  name:The Ohio State University
                  address:
                     name:Colleges of Public Health and Medicine, The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Inflammopharmacology
      issn:
         1568-5608
         0925-4692
      volumeNumber:26
Organization:
      name:Springer International Publishing
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:The Ohio State University
      address:
         name:Colleges of Public Health and Medicine, The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, USA
         type:PostalAddress
      name:The Ohio State University
      address:
         name:Colleges of Public Health and Medicine, The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Brian M. Kennedy
      affiliation:
            name:The Ohio State University
            address:
               name:Colleges of Public Health and Medicine, The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, USA
               type:PostalAddress
            type:Organization
      name:Randall E. Harris
      affiliation:
            name:The Ohio State University
            address:
               name:Colleges of Public Health and Medicine, The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Colleges of Public Health and Medicine, The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, USA
      name:Colleges of Public Health and Medicine, The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(296)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Crossref

4.96s.